Free Trial

Chemed (CHE) Competitors

Chemed logo
$612.09 +2.92 (+0.48%)
Closing price 03:59 PM Eastern
Extended Trading
$611.72 -0.37 (-0.06%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CHE vs. LH, DGX, DVA, CRVL, AMED, MD, AMN, CCRN, OPCH, and BTSG

Should you be buying Chemed stock or one of its competitors? The main competitors of Chemed include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Option Care Health (OPCH), and BrightSpring Health Services (BTSG).

Chemed vs.

Laboratory Co. of America (NYSE:LH) and Chemed (NYSE:CHE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends, community ranking and institutional ownership.

95.9% of Laboratory Co. of America shares are owned by institutional investors. Comparatively, 95.8% of Chemed shares are owned by institutional investors. 0.9% of Laboratory Co. of America shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Chemed has a net margin of 12.69% compared to Laboratory Co. of America's net margin of 5.73%. Chemed's return on equity of 27.86% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
Laboratory Co. of America5.73% 15.29% 7.01%
Chemed 12.69%27.86%19.12%

Laboratory Co. of America received 289 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 64.03% of users gave Laboratory Co. of America an outperform vote while only 63.50% of users gave Chemed an outperform vote.

CompanyUnderperformOutperform
Laboratory Co. of AmericaOutperform Votes
623
64.03%
Underperform Votes
350
35.97%
ChemedOutperform Votes
334
63.50%
Underperform Votes
192
36.50%

Laboratory Co. of America has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Chemed has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.2%. Chemed pays an annual dividend of $2.00 per share and has a dividend yield of 0.3%. Laboratory Co. of America pays out 32.7% of its earnings in the form of a dividend. Chemed pays out 10.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has raised its dividend for 16 consecutive years.

Laboratory Co. of America presently has a consensus price target of $269.92, suggesting a potential upside of 16.52%. Chemed has a consensus price target of $667.00, suggesting a potential upside of 8.97%. Given Laboratory Co. of America's higher possible upside, analysts plainly believe Laboratory Co. of America is more favorable than Chemed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.86
Chemed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Laboratory Co. of America has higher revenue and earnings than Chemed. Laboratory Co. of America is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Laboratory Co. of America$13.01B1.49$746M$8.8226.26
Chemed$2.43B3.68$272.51M$19.9130.74

In the previous week, Laboratory Co. of America had 5 more articles in the media than Chemed. MarketBeat recorded 15 mentions for Laboratory Co. of America and 10 mentions for Chemed. Chemed's average media sentiment score of 1.56 beat Laboratory Co. of America's score of 1.39 indicating that Chemed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Laboratory Co. of America
12 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemed
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Laboratory Co. of America and Chemed tied by winning 11 of the 22 factors compared between the two stocks.

Remove Ads
Get Chemed News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHE vs. The Competition

MetricChemedHome health care services IndustryMedical SectorNYSE Exchange
Market Cap$8.96B$3.22B$5.64B$19.63B
Dividend Yield0.33%0.33%4.56%3.74%
P/E Ratio30.9329.9423.1333.60
Price / Sales3.681.17383.8927.49
Price / Cash22.4017.2938.1617.54
Price / Book8.323.526.944.60
Net Income$272.51M-$57.02M$3.20B$1.02B
7 Day Performance1.71%2.12%-2.32%-0.16%
1 Month Performance4.43%4.78%3.07%-1.99%
1 Year Performance-4.90%21.64%11.16%4.91%

Chemed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHE
Chemed
4.5636 of 5 stars
$612.09
+0.5%
$667.00
+9.0%
-4.5%$8.96B$2.43B30.9314,200Positive News
LH
Laboratory Co. of America
4.7667 of 5 stars
$240.43
+0.4%
$268.38
+11.6%
+9.2%$20.12B$13.01B27.2675,500Positive News
DGX
Quest Diagnostics
4.837 of 5 stars
$173.62
+2.0%
$178.23
+2.7%
+29.4%$19.27B$9.87B22.5848,000Analyst Revision
DVA
DaVita
3.8552 of 5 stars
$149.22
+4.0%
$166.33
+11.5%
+11.9%$11.94B$12.82B13.8970,000Positive News
CRVL
CorVel
1.0998 of 5 stars
$106.21
-0.4%
N/A+30.3%$5.45B$871.31M62.484,230Positive News
AMED
Amedisys
3.1829 of 5 stars
$92.64
+0.1%
$100.75
+8.8%
+0.2%$3.04B$2.35B36.7620,000Positive News
MD
Pediatrix Medical Group
1.2495 of 5 stars
$14.26
+4.0%
$17.08
+19.8%
+53.9%$1.22B$2.01B-11.895,170Positive News
AMN
AMN Healthcare Services
4.3366 of 5 stars
$24.63
-7.9%
$41.17
+67.1%
-62.0%$940.60M$2.98B-6.403,585Analyst Upgrade
CCRN
Cross Country Healthcare
3.7934 of 5 stars
$15.32
-1.7%
$18.41
+20.1%
-18.6%$502.70M$1.34B-306.342,700Short Interest ↓
OPCH
Option Care Health
3.9529 of 5 stars
$33.89
+3.8%
$33.00
-2.6%
+6.6%$5.60B$5.00B28.485,600Positive News
BTSG
BrightSpring Health Services
2.7063 of 5 stars
$17.45
+0.2%
$21.67
+24.2%
+87.3%$3.05B$11.27B-67.1235,000
Remove Ads

Related Companies and Tools


This page (NYSE:CHE) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners